Global Human Microbiome Market By Type (Bacterial Consortia Transplantation (BCT)/Fecal Microbiota Transplantation (FMT), Peptides, Live Biotherapeutic Products, Other Types) By Product (Drugs, Probiotics and Prebiotics, Medical Foods, Supplements, Others) By Application ( Therapeutics , Diagnostics) By Disease Type (Infectious Diseases , Autoimmune Disorder, Gastrointestinal Disorders, Cancer, Other Diseases) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Feb 2024
- Report ID: 84270
- Number of Pages: 364
- Format:
-
-
-
- Seres Therapeutics
- Biomesense
- Microbiotica
- Infant Bacterial Therapeutics AB
- Vedanta Biosciences Inc.
- Second genome therapeutics
- 4D Pharma Ferring Inc
- Enterome
- BiomX
- MaaT Pharma
- Azitra
- Illumina Inc.
- Locus Biosciences Inc.
- Finch Therapeutics Group Inc.
- Rebiotix Inc
- Servatus Ltd
- Microbiome Research Pvt. Ltd
- AOBiome
- Axial Therapeutics Inc
- Biomica
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |